Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Sokolove Jeremy Brett, holds the title of Chief Medical Officer at Vor Biopharma Inc..
On 2026-11-02, the insider transacted 1,917 shares.The shares were transacted at a weighted average price of $19.25 per share, resulting in a total market-relevant value of $37K.
Sokolove Jeremy Brett (Chief Medical Officer) had withheld for taxes $37K of $VOR
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.